Berger BE, Ferrans CE, Lashley FR Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001 Dec;24(6):518-29.
Chang L, Ernst T, Leonido-Yee M, Speck O Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology. 2000 Jan 25;54(2):389-96.
Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000 Jun;12(3):255-66.
Chesney MA The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S149-55.
Claborn KR, Meier E, Miller MB, Leffingwell TR A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychol Health Med. 2015;20(3):255-65. doi: 10.1080/13548506.2014.945601. Epub 2014 Aug 11. Review.
Contardo C, Black AC, Beauvais J, Dieckhaus K, Rosen MI Relationship of prospective memory to neuropsychological function and antiretroviral adherence. Arch Clin Neuropsychol. 2009 Sep;24(6):547-54. doi: 10.1093/arclin/acp046. Epub 2009 Jul 31.
Gonzalez JS, Hendriksen ES, Collins EM, Durán RE, Safren SA Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav. 2009 Jun;13(3):582-602. doi: 10.1007/s10461-008-9402-4. Epub 2008 May 23.
Kalichman S, Pellowski J, Chen Y Requesting help to understand medical information among people living with HIV and poor health literacy. AIDS Patient Care STDS. 2013 Jun;27(6):326-32. doi: 10.1089/apc.2013.0056. Epub 2013 May 23.
Lovejoy TI, Suhr JA The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med. 2009 Oct;32(5):389-405. doi: 10.1007/s10865-009-9212-9. Epub 2009 Mar 17. Review.
Malta M, Magnanini MM, Strathdee SA, Bastos FI Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010 Aug;14(4):731-47. doi: 10.1007/s10461-008-9489-7. Epub 2008 Nov 20.
Nieuwkerk PT, Oort FJ Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):445-8.
Oh DL, Sarafian F, Silvestre A, Brown T, Jacobson L, Badri S, Detels R Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among White, Hispanic, and Black men in the MACS Cohort. J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):290-3. doi: 10.1097/QAI.0b013e3181ab6d48.
Pellowski JA, Kalichman SC, Grebler T Optimal Treatment Adherence Counseling Outcomes for People Living with HIV and Limited Health Literacy. Behav Med. 2016 Jan-Mar;42(1):39-47. doi: 10.1080/08964289.2014.963006. Epub 2014 Dec 13.
Pellowski JA, Kalichman SC, White D, Amaral CM, Hoyt G, Kalichman MO Real-time medication adherence monitoring intervention: test of concept in people living with HIV infection. J Assoc Nurses AIDS Care. 2014 Nov-Dec;25(6):646-51. doi: 10.1016/j.jana.2014.06.002. Epub 2014 Jul 16.
Pellowski JA, Kalichman SC Health behavior predictors of medication adherence among low health literacy people living with HIV/AIDS. J Health Psychol. 2015 Feb 20. pii: 1359105315569617. [Epub ahead of print]
Turner BJ Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis. 2002 May 15;185 Suppl 2:S143-51. Review.
Wagner GJ Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDS. 2002 Dec;16(12):599-608.
Woods SP, Moore DJ, Weber E, Grant I Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009 Jun;19(2):152-68. doi: 10.1007/s11065-009-9102-5. Epub 2009 May 22. Review.
A Cognitive Rehabilitation Program to Promote Treatment Adherence for Individuals Who Are HIV Positive With Mild Neurocognitive Difficulties
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.